Search | IOVS | ARVO Journals

iovs

Issues
Topics
For Authors
About
- Editorial Board

Journals Home

MANAGE ALERTS

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board

Narrow View

NARROW

Content Type

Meeting Abstract (6)
Journal Articles (2)

Journal

Investigative Ophthalmology & Visual Science (8)

Article Type

ARVO Annual Meeting Abstract (6)
Cornea (2)

Topics

Cornea (2)
Eye Anatomy and Disorders (2)
Genetics (2)
Immunology and Microbiology (1)
Pharmacology (1)

Tags

hereditary corneal dystrophy (2)
anti-inflammatory agents, non-steroidal (1)
biotinylation (1)
diclofenac (1)
dimethyl sulfoxide (1)
eye (1)
glafenine (1)
mutation (1)
nepafenac (1)
proteins (1)

Specify Date Range

From: To: Apply

Showing 1 – 8 of 8

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Long noncoding RNAs (LncRNAs) and the metabolic memory associated with the continued progression of diabetic retinopathy

Jay Kumar; Ghulam Mohammad; Kumari Alka; Renu A. Kowluru

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1003.

ARVO Annual Meeting Abstract June 2023

Regulation of Mitochondrial Dynamics and the Metabolic Memory Associated with the Continued Progression of Diabetic Retinopathy

Kumari Alka; Renu A. Kowluru

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2426.

ARVO Annual Meeting Abstract June 2022

Diabetic Retinopathy: Regulation of Ceramide Production and Rac1 Activation

Kumari Alka; Renu A Kowluru

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):785 – F0344.

Cornea August 2018

Ophthalmic Nonsteroidal Anti-Inflammatory Drugs as a Therapy for Corneal Dystrophies Caused by SLC4A11 Mutation

PDF

Kumari Alka; Joseph R. Casey
TAGS: anti-inflammatory agents, non-steroidal, diclofenac, eye, hereditary corneal dystrophy, mutation, water, nepafenac
Invest. Ophthalmol. Vis. Sci.. 2018; 59(10):4258-4267. https://doi.org/10.1167/iovs.18-24301

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2017

Rescue of Corneal Dystrophy-Causing SLC4A11 Mutants by Ophthalmological Non-Steroidal Anti-inflammatory Drugs

Kumari Alka; Joseph R Casey

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5654.

ARVO Annual Meeting Abstract September 2016

SLC4A11 Three-Dimensional Model Explains Structural Basis for Endothelial Corneal Dystrophy-Causing Mutations

Kumari Alka; Katherine E Badior; Joseph R Casey

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4820.

Cornea December 2015

High Throughput Assay Identifies Glafenine as a Corrector for the Folding Defect in Corneal Dystrophy–Causing Mutants of SLC4A11

PDF

Anthony M. Chiu; Jake J. Mandziuk; Sampath K. Loganathan; Kumari Alka; Joseph R. Casey
TAGS: glafenine, hereditary corneal dystrophy, proteins, biotinylation, dimethyl sulfoxide
Invest. Ophthalmol. Vis. Sci.. 2015; 56(13):7739-7753. https://doi.org/10.1167/iovs.15-17802

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2015

A Personalized Medicine Approach to Corneal Dystrophy: Assessment of All Reported Missense SLC4A11 Mutants as Candidates for Folding Correction

Kumari Alka; Joseph R Casey

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4660.

« Previous

Advertisement

Follow @ARVOiovs

IOVS Home
Issues
Topics
For Authors
About
- Editorial Board

Online ISSN: 1552-5783

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2025 Association for Research in Vision and Ophthalmology.

Access Provided By:
MIT Libraries

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept